Nourollah Sadeghzadeh

Dr. Nourollah Sadeghzadeh


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2018 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
PDF file
FRFarzaneh Rezazadeh
Farzaneh Rezazadeh
NSNourollah Sadeghzadeh
Nourollah Sadeghzadeh

1 July 2018 in Nuclear Medicine and Biology
Verified
Journal Article
Closed access
FRFarzaneh Rezazadeh
Farzaneh Rezazadeh
NSNourollah Sadeghzadeh
Nourollah Sadeghzadeh
SASeyed Mohammad Abedi
Seyed Mohammad Abedi
SASaeid Abediankenari
Saeid Abediankenari

1 June 2020 in Bioorganic Chemistry
Verified
Journal Article
Closed access
FMFariba Maleki
Fariba Maleki
AFArezou Masteri Farahani
Arezou Masteri Farahani
FRFarzaneh Rezazedeh
Farzaneh Rezazedeh
NSNourollah Sadeghzadeh
Nourollah Sadeghzadeh

26 March 2013 in Journal of Radioanalytical and Nuclear Chemistry
Verified
Journal Article
Open access
PDF file
NSNourollah Sadeghzadeh
Nourollah Sadeghzadeh
MAM. Ahmadzadeh
M. Ahmadzadeh
MEM. Erfani
M. Erfani
Gastrin-releasing peptide (GRP) receptors are over-expressed in various human tumor including breast and prostate which can be targeted with bombesin for diagnosis and targeted therapy. High abdominal accumulation and the poor in vivo stability of radiolabeled bombesin analogues may represent a limitation for diagnostic imaging and targeted therapy. In this study a new bombesin derivative was labeled with 99mTc via HYNIC and tricine as a coligand and investigated further. The peptide HYNIC conjugate was synthesized on a solid phase using Fmoc strategy. Labeling with 99mTc was performed at 100 °C for 10 min and radiochemical analysis involved ITLC and HPLC methods. The stability of radiopeptide was checked in the presence of human serum at 37 °C up to 24 h. Internalization was studied with the human GRP receptor cell line PC-3. The Biodistribution was studied in mice. Labeling yield of >98 % was obtained to correspond a specific activity of ~80.9 GBq/μmol. Radioconjugate internalization into PC-3 cells was high and specific (15.6 ± 1.9 % at 4 h). A high and specific uptake in GRP-receptor-positive organs such as mouse tumor and pancreas (2.11 ± 0.18 and 1.78 ± 0.09 % ID/g after 1 h respectively) was also determined.

12 April 2020 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
PDF file
AFArezou Masteri Farahani
Arezou Masteri Farahani
FMFariba Maleki
Fariba Maleki
NSNourollah Sadeghzadeh
Nourollah Sadeghzadeh
SASaeid Abediankenari
Saeid Abediankenari
SASeyed Mohammad Abedi
Seyed Mohammad Abedi
MEMostafa Erfani
Mostafa Erfani

15 May 2020 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
AFArezou M. Farahani
Arezou M. Farahani
FMFariba Maleki
Fariba Maleki
NSNourollah Sadeghzadeh
Nourollah Sadeghzadeh
Background: Cancer is the leading cause of death worldwide. Early detection can reduce the disadvantageous effects of diseases and the mortality in cancer. Nuclear medicine is a powerful tool that has the ability to diagnose malignancy without harming normal tissues. In recent years, radiolabeled peptides have been investigated as potent agents for cancer detection. Therefore, it is necessary to modify radiopeptides in order to achieve more effective agents. Objective: This review describes modifications in the structure of radioconjugates with spacers who have improved the specificity and sensitivity of the peptides that are used in oncologic diagnosis and therapy. Methods: To improve the biological activity, researchers have conjugated these peptide analogs to different spacers and bifunctional chelators. Many spacers of different kinds, such as hydrocarbon chain, amino acid sequence, and poly (ethyleneglycol) were introduced in order to modify the pharmacokinetic properties of these biomolecules. Results: Different spacers have been applied to develop radiolabeled peptides as potential tracers in nuclear medicine. Spacers with different charge and hydrophilicity affect the characteristics of peptide conjugate. For example, the complex with uncharged and hydrophobic spacers leads to increased liver uptake, while the composition with positively charged spacers results in high kidney retention. Therefore, the pharmacokinetics of radio complexes correlates to the structure and total charge of the conjugates. Conclusion: Radio imaging technology has been successfully applied to detect a tumor in the earliest stage. For this purpose, the assessment of useful agents to diagnose the lesion is necessary. Developing peptide radiopharmaceuticals using spacers can improve in vitro and in vivo behavior of radiotracers leading to better noninvasive detection and monitoring of tumor growth.